CHICAGO, March 27, 2025 (GLOBE NEWSWIRE) -- Vanqua Bio, a clinical-stage biopharmaceutical company, announced that the company will present at AD/PD™ 2025 International Conference on Alzheimer’s and ...

ARV-102 is Arvinas’ investigational PROteolysis TArgeting Chimera (PROTAC) degrader targeting leucine-rich repeat kinase 2 (LRRK2), a multifunctional protein that has been implicated in Parkinson’s ...

Some of the artist’s most psychologically insightful work came in the final years of his life — a mature period cut short by ...

Off to the big match in the capitalOff we go to Vienna on Easter Sunday: On 20 April 2025 at 17:00 we are away in the Bundesliga's Championship Group at FK Austria Vienna. Info on ticket presales for ...

Following World Water Day on March 22, CNH brands - Case IH and New Holland - continue to lead the way in breaking new ground ...

Photojournalist Armineh Johannes took part in the 5th World Masters of Photography Award 2025, which concluded on March 31 at ...

BMW Art Car World Tour runs globally from March to September, and began with Lichtenstein, Warhol, Rauschenberg, Hockney, and ...

The Wayside Digitalisation Forum will take place on 15–17 October 2025 in Vienna, with a focus on the future of digital signalling.

Linus Health will deliver poster presentations at AD/PD from two clinical studies evaluating the accuracy, efficacy, and ...

Anixa Biosciences signed a letter of intent with VERDI Solutions to develop AI-powered personalized and off-the-shelf cancer ...

AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD™ 2025 AC Immune to host symposium highlighting the company’s industry-leading pipeline of active ...